{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:18:02Z","timestamp":1793751482614,"version":"4.6.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>\n                    The gene\n                    <jats:italic toggle=\"yes\">CDC73<\/jats:italic>\n                    (previously known as\n                    <jats:italic toggle=\"yes\">HRPT2<\/jats:italic>\n                    ) encodes the protein parafibromin. Biallelic mutation of\n                    <jats:italic toggle=\"yes\">CDC73<\/jats:italic>\n                    is strongly associated with malignancy in parathyroid tumors. Heterozygous germline mutations cause hyperparathyroidism jaw tumor syndrome,which is associated with a high life-time risk of parathyroid carcinoma. Therefore loss of parafibromin expression by immunohistochemistry may triage genetic testing for hyperparathyroidism jaw tumor syndrome and be associated with malignant behavior in atypical parathyroid tumors. We share our experience that parafibromin-negative parathyroid tumors show distinctive morphology. We searched our institutional database for parathyroid tumors demonstrating complete loss of nuclear expression of parafibromin with internal positive controls. Forty-three parafibromin-negative tumors from 40 (5.1%) of 789 patients undergoing immunohistochemistry were identified. Thirty-three (77%) were external consultation cases; the estimated incidence in unselected tumors was 0.19%. Sixteen (37.2%) fulfilled World Health Organization 2017 criteria for parathyroid carcinoma and 63% had serum calcium greater than 3mmol\/L. One of 27 (3.7%) noninvasive but parafibromin-negative tumors subsequently metastasized. Parafibromin-negative patients were younger (mean, 36 vs. 63\u2009y;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) and had larger tumors (mean, 3.04 vs. 0.62\u2009g;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). Not all patients had full testing, but 26 patients had pathogenic\n                    <jats:italic toggle=\"yes\">CDC73<\/jats:italic>\n                    mutation\/deletions confirmed in tumor (n=23) and\/or germline (n=16). Parafibromin-negative tumors demonstrated distinctive morphology including extensive sheet-like rather than acinar growth, eosinophilic cytoplasm, nuclear enlargement with distinctive coarse chromatin, perinuclear cytoplasmic clearing, a prominent arborizing vasculature, and, frequently, a thick capsule. Microcystic change was found in 21 (48.8%). In conclusion, there are previously unrecognized morphologic clues to parafibromin loss\/\n                    <jats:italic toggle=\"yes\">CDC73<\/jats:italic>\n                    mutation in parathyroid tumors which, given the association with malignancy and syndromic disease, are important to recognize.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001017","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T18:37:32Z","timestamp":1515695852000},"page":"35-46","source":"Crossref","is-referenced-by-count":114,"title":["Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features"],"prefix":"10.1097","volume":"43","author":[{"given":"Anthony J.","family":"Gill","sequence":"first","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lim","sequence":"additional","affiliation":[{"name":"Cancer Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica K.Y.","family":"Cheung","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Andrici","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Perry-Keene","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Pathology Queensland, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Paik","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Sioson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Clarkson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Sheen","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Luxford","sequence":"additional","affiliation":[{"name":"Cancer Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne S.","family":"Elston","sequence":"additional","affiliation":[{"name":"Endocrinology"},{"name":"Faculty of Medicine and Health Sciences, University of Auckland, Waikato Clinical Campus, Hamilton, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goswin Y.","family":"Meyer-Rochow","sequence":"additional","affiliation":[{"name":"Surgery, Waikato Hospital"},{"name":"Faculty of Medicine and Health Sciences, University of Auckland, Waikato Clinical Campus, Hamilton, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Nano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Brisbane and Women\u2019s Hospital, Herston, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schelto","family":"Kruijff","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton F.","family":"Engelsman","sequence":"additional","affiliation":[{"name":"University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, St Leonards"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sywak","sequence":"additional","affiliation":[{"name":"University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, St Leonards"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley B.","family":"Sidhu","sequence":"additional","affiliation":[{"name":"University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, St Leonards"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh W.","family":"Delbridge","sequence":"additional","affiliation":[{"name":"University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, St Leonards"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Royal North Shore Hospital"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Marsh","sequence":"additional","affiliation":[{"name":"Hormones and Cancer Group, Kolling Institute of Medical Research"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Toon","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Sydney Medical School, University of Sydney, Sydney"},{"name":"Histopath Pathology, Macquarie Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chou","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research"},{"name":"Sydney Medical School, University of Sydney, Sydney"},{"name":"Department of Anatomical Pathology, SYDPATH, St Vincent\u2019s Hospital"},{"name":"The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick J.","family":"Clifton-Bligh","sequence":"additional","affiliation":[{"name":"Cancer Genetics"},{"name":"Department of Endocrinology, Royal North Shore Hospital"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidsim-jaw tumor (HPT-JT) syndrome related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the genetic basis of parathyroid carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","article-title":"Identification of a functional bipartite localization signal in the tumor suppressor parafibromin","volume":"15","author":"Hahn","year":"2005","journal-title":"Oncogene"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1038\/ncomms6433","article-title":"Cytoplasmic parafibromin\/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis","volume":"12","author":"Jo","year":"2014","journal-title":"Nat Commun"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"15741","DOI":"10.1038\/ncomms15741","article-title":"Architecture of the RNA polymerase II-Paf1C-TFIIS transcription elongation complex","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestatons and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","article-title":"Hereditary hyperparathyroidism\u2014a consensus report of the European Society of Endocrine Surgeons (ESES)","volume":"400","author":"Iacobone","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1158\/1078-0432.CCR-17-0548","article-title":"Multiple endocrine neoplasia and hyperparathyroid-jaw tumor syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Wasserman","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumours","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocinol Metab"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","article-title":"HRPT mutation analysis of typical sporadic parathyroid adenomas","volume":"90","author":"Krebs","year":"2005","journal-title":"J Clin Endocinol Metab"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMp038159","article-title":"Perspective: HRPT2, a marker of parathyroid cancer","volume":"349","author":"Weinstein","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","article-title":"Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification","volume":"14","author":"Juhlin","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","article-title":"Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma","volume":"94","author":"Howell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","article-title":"Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","article-title":"Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00423-015-1361-4","article-title":"Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism","volume":"401","author":"Ozolins","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PAP.0b013e3180ca8ad0","article-title":"Parafibromin in the diagnosis of parathyroid carcinoma","volume":"14","author":"Mangray","year":"2007","journal-title":"Adv Anatomic Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jamcollsurg.2014.10.007","article-title":"Modern experience with aggressive parathyroid tumors in a high-volume. New England referral center","volume":"220","author":"Quinn","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","article-title":"Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma","volume":"19","author":"Delellis","year":"2008","journal-title":"Endocr Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12022-015-9378-3","article-title":"Oxyphil cell parathyroid adenomas causing primary hyperparathyroidism: a clinico-pathological correlation","volume":"26","author":"Howson","year":"2015","journal-title":"Endocr Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00313025.2010.493871","article-title":"Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma","volume":"42","author":"Hall","year":"2010","journal-title":"Pathology"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol (Dordr)"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behaviour in atypical parathyroid adenomas","volume":"21","author":"Krujiff","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/cncr.22790","article-title":"Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?","volume":"110","author":"Fernandez-Ranvier","year":"2007","journal-title":"Cancer"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","article-title":"Clinical course of metastatic parathyroid carcinoma","volume":"18","author":"Sandelin","year":"1994","journal-title":"World J Surg"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/bjs.5570","article-title":"Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma","volume":"94","author":"Ippolito","year":"2007","journal-title":"Br J Surg"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A nationwide study on parathyroid carcinoma","volume":"56","author":"Ryhanen","year":"2017","journal-title":"Acta Oncol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","article-title":"Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations","volume":"143","author":"Sarquis","year":"2008","journal-title":"Surgery"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1445-5994.2011.02545.x","article-title":"Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma\u2014the role of parafibromin in increasing diagnostic accuracy","volume":"41","author":"Lim","year":"2011","journal-title":"Intern Med J"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17530059.1.3.377","article-title":"Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes","volume":"1","author":"Marsh","year":"2007","journal-title":"Expert Opin Med Diagn"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","article-title":"Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred","volume":"394","author":"Iacobone","year":"2009","journal-title":"Langenbecks Arch Surg"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","article-title":"Hyperparathyroidism-jaw tumor syndrome: results of operative management","volume":"156","author":"Mehta","year":"2014","journal-title":"Surgery"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1590\/S0004-27302008000800003","article-title":"HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach?","volume":"52","author":"Silveira","year":"2008","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","article-title":"Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas","volume":"21","author":"Juhlin","year":"2010","journal-title":"Endocr Pathol"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-012-9222-y","article-title":"Biomarkers of parathyroid carcinoma","volume":"23","author":"Erovic","year":"2012","journal-title":"Endocr Pathol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","article-title":"Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis","volume":"54","author":"Hu","year":"2016","journal-title":"Endocrine"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","article-title":"Role of histological criteria and immunohistochemical markers in predicting risk of malignancy in parathyroid neoplasms","volume":"27","author":"Kumari","year":"2016","journal-title":"Endocr Pathol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201901000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:46:53Z","timestamp":1695408413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201901000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001017","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}